Access cutting-edge idiopathic hypersomnia treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access idiopathic hypersomnia specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related idiopathic hypersomnia treatment provided free
Low sodium oxybate has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic hypersomnia. In this study, the researchers want to learn how low sodium oxybate impacts ability of people diagnosed with idiopathic hypersomnia to sleep for long periods of time. In addition, this study will use novel tools to determine when an individual is awake or asleep.
Sponsor: Mayo Clinic
Check if you qualify for this idiopathic hypersomnia clinical trial in Boston, MA
If you're searching for idiopathic hypersomnia treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced idiopathic hypersomnia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.